Dr. Prasad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
261 James Street
Suite 2G
Morristown, NJ 07960Phone+1 973-539-0333
Summary
- Dr. Sandip Prasad is an urologist in Morristown, NJ and is affiliated with Morristown Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice 12 years. He specializes in minimally invasive surgery, stone disease, and surgical oncology and is experienced in prostate cancer, gynecologic oncology, urologic oncology, minimally invasive urologic surgery, and urologic trauma and reconstructive surgery.
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 2006 - 2010
- Brigham and Womens HospitalInternship, Transitional Year, 2005 - 2006
- Duke University School of MedicineClass of 2005
- University of CambridgeMphil, Epidemiology, With Distinction, 1998 - 1999
- Harvard UniversityA.B., Environmental Science and Public Policy, Magna cum laude, 1994 - 1998
Certifications & Licensure
- NJ State Medical License 2017 - 2025
- SC State Medical License 2012 - 2017
- IL State Medical License 2010 - 2014
- MA State Medical License 2008 - 2010
- American Board of Urology Urology
Awards, Honors, & Recognition
- Merit Award ASCO Cancer Foundation, 2010
- Outstanding poster presentation American Urological Association, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2013 Oct 14
Publications & Presentations
PubMed
- 22 citationsFactors associated with the adoption of minimally invasive radical prostatectomy in the United StatesWilliam D. Ulmer, Sandip M. Prasad, Keith J. Kowalczyk, Xiangmei Gu, Christopher M. Dodgion
The Journal of Urology. 2012-09-01 - 26 citationsEarly discharge after laparoscopic or robotic partial nephrectomy: care pathway evaluation.Amit R. Patel, Shay Golan, Aria Razmaria, Sandip M. Prasad, Scott E. Eggener
BJU International. 2014-04-01 - 6 citationsTreatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection ...Sandip M Prasad, William C Huang, Neal D Shore, Brian Hu, Marc Bjurlin
The Journal of Urology. 2023-10-01
Journal Articles
- Early discharge after laparoscopic or robotic partial nephrectomy: care pathway evaluationPatel A, Golan S, Razmaria A, Prasad S, Eggener S, Shalhav A, British Journal of Urology International, 1/1/2014
- Does robotic-assisted laparoscopic ileocystoplasty (RALI) reduce peritoneal adhesions compared to open surgeryRazmaria AA, Marchetti PE, Prasad SM, Shalhav AL, Gundeti MS, British Journal of Urology International, 1/1/2014
- Ultrasonography in prostate cancer: current roles and potential applications in radiorecurrent diseaseRosoff JS, Prasad SM, Savage SJ, World Journal of Urology, 1/1/2013
- Join now to see all
Press Mentions
- ENVISION Trial Results Published in the Journal of Urology Report 82.3% Duration of Response 12 Months After Achieving Complete Response for UGN-102, Potentially First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBCOctober 28th, 2024
- 7 Studies at American Society of Clinical Oncology (ASCO) Annual Meeting Presented by Atlantic Health System Cancer Care Physician ResearchersJune 7th, 2021
- Prostate Cancer ADT Found to Increase Depression RiskApril 22nd, 2019
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: